Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dosimetry prior to I-131-therapy of benign thyroid diseaseHeribert Hänscheid, Michael Lassmann, Christoph ReinersZeitschrift Fur Medizinische Physik|November 14, 2022
Determinants of target absorbed dose in radionuclide therapyHeribert Hänscheid, Michael Lassmann, Frederik A VerburgJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Impact of 131I diagnostic activities on the biokinetics of thyroid remnantsMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.Endocrine-Related Cancer|July 25, 2009
Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinomaHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.Nature Reviews. Endocrinology|August 10, 2011
Radioiodine for remnant ablation and therapy of metastatic diseaseChristoph Reiners, Heribert Hänscheid, Markus Luster, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2017
Dose Mapping After Endoradiotherapy with <sup>177</sup>Lu-DOTATATE/DOTATOC by a Single Measurement After 4 DaysHeribert Hänscheid, Constantin Lapa, Andreas K Buck, et al.Nuklearmedizin. Nuclear Medicine|March 14, 2018
Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOCHeribert Hänscheid, Constantin Lapa, Andreas K Buck, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2008
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapyMichael Lassmann, Heribert Hänscheid, Carlo Chiesa, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patientsFrederik A Verburg, Michael Lassmann, Uwe Mäder, et al.EJNMMI Physics|April 8, 2025
Non-linear mixed-effects modelling and population-based model selection for <sup>131</sup>I kinetics in benign thyroid diseaseDeni Hardiansyah, Ade Riana, Heribert Hänscheid, et al.Pageof 18